| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 22,285 | 23,049 | 23,976 | 22,263 | | Cost of Revenue | 16,629 | 16,812 | 17,965 | 16,304 | | | Gross Profit | 5,656 | 6,237 | 6,010 | 5,959 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,468 | 6,023 | 5,332 | 5,389 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 188 | 213 | 679 | 570 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6 | 14 | 40 | 489 | | Earnings Before Interest And Taxes | (798) | 228 | 719 | 1,059 | | Interest Expense | (420) | 227 | 193 | 190 | | Income Before Tax | (378) | 1 | 525 | 869 | | Income Tax Expense | (187) | (7) | 428 | 210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (190) | 8 | 97 | 659 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (190) | 8 | 97 | 659 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($190) | $8 | $97 | $659 |
|
0.51% Nasdaq 
Income Statement
